litlas
ログインアカウント作成

Stuart C. Gordon

1984–2025 年に発表

113
論文数
35,272
被引用数
79
h 指数
108
i10 指数

被引用数

Stuart C. Gordon の年別被引用数1985 年: 被引用 1 件1986 年: 被引用 2 件1987 年: 被引用 1 件1988 年: 被引用 2 件1989 年: 被引用 2 件1990 年: 被引用 1 件1991 年: 被引用 2 件1992 年: 被引用 4 件1993 年: 被引用 3 件1994 年: 被引用 4 件1995 年: 被引用 5 件1996 年: 被引用 4 件1997 年: 被引用 13 件1998 年: 被引用 13 件1999 年: 被引用 56 件2000 年: 被引用 118 件2001 年: 被引用 118 件2002 年: 被引用 215 件2003 年: 被引用 178 件2004 年: 被引用 189 件2005 年: 被引用 214 件2006 年: 被引用 197 件2007 年: 被引用 194 件2008 年: 被引用 161 件2009 年: 被引用 151 件2010 年: 被引用 199 件2011 年: 被引用 201 件2012 年: 被引用 206 件2013 年: 被引用 220 件2014 年: 被引用 318 件2015 年: 被引用 374 件2016 年: 被引用 349 件2017 年: 被引用 268 件2018 年: 被引用 252 件2019 年: 被引用 768 件2020 年: 被引用 639 件2021 年: 被引用 504 件2022 年: 被引用 388 件2023 年: 被引用 296 件2024 年: 被引用 490 件2025 年: 被引用 213 件2026 年: 被引用 2 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,667 件、この内訳の 28.4%イギリス: 引用元論文 579 件、この内訳の 6.1%フランス: 引用元論文 570 件、この内訳の 6.1%ドイツ: 引用元論文 564 件、この内訳の 6%イタリア: 引用元論文 562 件、この内訳の 6%中国: 引用元論文 542 件、この内訳の 5.8%カナダ: 引用元論文 337 件、この内訳の 3.6%日本: 引用元論文 328 件、この内訳の 3.5%スペイン: 引用元論文 304 件、この内訳の 3.2%オーストラリア: 引用元論文 262 件、この内訳の 2.8%ベルギー: 引用元論文 189 件、この内訳の 2%オランダ: 引用元論文 183 件、この内訳の 1.9%
0%28.4%その他 24.6%

機関

分野

  • Medicine90.2%
  • Biochemistry, Genetics and Molecular Biology3.4%
  • Immunology and Microbiology2.6%
  • Pharmacology, Toxicology and Pharmaceutics0.9%
  • Neuroscience0.4%
  • Chemistry0.4%
  • その他2.1%

トピック

  • Hepatitis C virus research17.7%
  • Liver Disease Diagnosis and Treatment15.1%
  • Hepatitis B Virus Studies9.3%
  • Liver Diseases and Immunity3.9%
  • Liver Disease and Transplantation3.7%
  • HIV/AIDS drug development and treatment3.6%
  • その他46.7%

共著者

全論文

検索で開く
  1. Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    著者: Vlad Ratziu, Stephen A. Harrison, Sven Francque, Pierre Bédossa, Philippe Lehert, Lawrence Serfaty, Manuel Romero‐Gómez, Jérôme Boursier, Manal F. Abdelmalek, Steve Caldwell, Joost P.H. Drenth, Quentin M. Anstee, Dean W. Hum, Rémy Hanf, A. Roudot, S. Megnien, Bart Staels, Arun J. Sanyal, Philippe Mathurin, Jérôme Gournay, Éric Nguyen-Khac, Victor de Lédinghen, Dominique Larrey, Albert Tran, Marc Bourlière, M. Maynard-Muet, Tarik Asselah, Jean Henrion, Frederik Nevens, David Cassiman, Anja Geerts, Christophe Moreno, Ulrich Beuers, Peter R. Galle, U. Spengler, Elisabetta Bugianesi, Antonio Craxı̀, M. Angélico, Silvia Fargion, M Voiculescu, Liliana Gheorghe, Liliana Preoțescu, Juan Caballería, Raúl J. Andrade, Javier Crespo, J.L. Callera, Aftab Ala, Guruprasad P. Aithal, George Abouda, Velimir A. Luketic, Mao-Yu Huang, Stuart C. Gordon, Paul J. Pockros, Fred Poordad, Nathan J. Shores, Martin Moehlen, Kiran Bambha, Virginia Clark, Sanjaya K. Satapathy, Samir Parekh, R.K. Reddy, Muhammad Y. Sheikh, Gyöngyi Szabó, John M. Vierling, Timothy E. Foster, Guillermo E. Umpierrez, Chih‐Jen Chang, Terry Box, Juan F. Gallegos‐Orozco - Gastroenterology 2016 被引用: 1,014

  2. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

    著者: Zobair M. Younossi, Saleh A. Alqahtani, Khalid Alswat, Yusuf Yılmaz, Çağlayan Keklikkıran, Jesús Funuyet‐Salas, Manuel Romero‐Gómez, Jian‐Gao Fan, Ming‐Hua Zheng, Mohamed El‐Kassas, Laurent Castéra, Chun‐Jen Liu, Vincent Wai‐Sun Wong, Shira Zelber‐Sagi, Alina M. Allen, Brian Lam, Sombat Treeprasertsuk, Saeed Hameed, Hirokazu Takahashi, Takumi Kawaguchi, Jörn M. Schattenberg, Ajay Duseja, Philip N. Newsome, Sven Francque, C Wendy Spearman, Marlen I. Castellanos Fernández, Patrizia Burra, Stuart K. Roberts, Wah‐Kheong Chan, Marco Arrese, Marcelo Silva, Mary E. Rinella, Ashwani K. Singal, Stuart C. Gordon, Michael Fuchs, Naim Alkhouri, Kenneth Cusi, Rohit Loomba, Jane Ranagan, Wayne Eskridge, Achim Kautz, Janus P. Ong, Marcelo Kugelmas, Yuichiro Eguchi, M. Diago, Ming‐Lung Yu, Lynn H. Gerber, Lisa Fornaresio, Fatema Nader, Linda Henry, Andrei Racila, Pegah Golabi, Maria Stepanova, Patrizia Carrieri, Jeffrey V. Lazarus - Journal of Hepatology 2023 被引用: 96

  3. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

    著者: Gideon M. Hirschfield, Mitchell L. Shiffman, Aliya Gulamhusein, Kris V. Kowdley, John M. Vierling, Cynthia Levy, Andreas E. Kremer, Ehud Zigmond, Pietro Andreoné, Stuart C. Gordon, Christopher L. Bowlus, Eric Lawitz, Richard Aspinall, Daniel S. Pratt, K. L. Raikhelson, M.S. González-Huezo, Michael A. Heneghan, Sook‐Hyang Jeong, Alma Laura Ladrón De Guevara, Marlyn J. Mayo, George Ν. Dalekos, Joost P.H. Drenth, Ewa Janczewska, Barbara Leggett, Frederik Nevens, Vı́ctor Vargas, Eli Zuckerman, Christophe Corpechot, E Fassio, Holger Hinrichsen, Pietro Invernizzi, Palak Trivedi, Lisa Forman, David E.J. Jones, Stephen Ryder, Mark G. Swain, Alexandra Steinberg, Pol Boudes, Yun‐Jung Choi, Charles A. McWherter, ENHANCE Study Group* - Hepatology 2023 被引用: 113

  4. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

    著者: AASLD-IDSA HCV Guidance Panel, Raymond T. Chung, Marc G. Ghany, Arthur Y Kim, Kristen Marks, Susanna Naggie, Hugo E. Vargas, Andrew Aronsohn, Debika Bhattacharya, Tina Broder, Oluwaseun Falade‐Nwulia, Robert J. Fontana, Stuart C. Gordon, Theo Heller, Scott D. Holmberg, Ravi Jhaveri, Maureen M. Jonas, Jennifer J. Kiser, Benjamin P. Linas, Vincent Lo Re, Timothy R. Morgan, Ronald Nahass, Marion G. Peters, K. Rajender Reddy, Andrew Reynolds, John D. Scott, Gloria Searson, Tracy Swan, Norah A. Terrault, Stacey Trooskin, John B. Wong, Kimberly Workowski - Clinical Infectious Diseases 2018 被引用: 726

  5. Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid

    著者: Gideon M. Hirschfield, Andrew L. Mason, Velimir A. Luketic, Keith D. Lindor, Stuart C. Gordon, Marlyn J. Mayo, Kris V. Kowdley, Catherine Vincent, Henry C. Bodhenheimer, Albert Parés, Michael Trauner, Hanns–Ulrich Marschall, Luciano Adorini, Cathi Sciacca, T. Beecher-Jones, Erin Castelloe, O. Böhm, Д. А. Шапиро - Gastroenterology 2014 被引用: 565

  6. Clinical and Patient-Reported Outcomes From Patients With Nonalcoholic Fatty Liver Disease Across the World: Data From the Global Non-Alcoholic Steatohepatitis (NASH)/ Non-Alcoholic Fatty Liver Disease (NAFLD) Registry

    著者: Zobair M. Younossi, Yusuf Yılmaz, Ming‐Lung Yu, Vincent Wai‐Sun Wong, Marlen Castellanos Fernández, Isakov Va, Ajay Duseja, Nahúm Méndez‐Sánchez, Yuichiro Eguchi, Elisabetta Bugianesi, Patrizia Burra, Jacob George, Jian‐Gao Fan, George Papatheodoridis, Wah‐Kheong Chan, Khalid Alswat, Hamid S. Saeed, Ashwani K. Singal, Manuel Romero‐Gómez, Stuart C. Gordon, Stuart K. Roberts, Mohamed El‐Kassas, Marcelo Kugelmas, Janus P. Ong, Saleh A. Alqahtani, Mariam Ziayee, Brian Lam, Issah Younossi, Andrei Racila, Linda Henry, Maria Stepanova - Clinical Gastroenterology and Hepatology 2021 被引用: 106

  7. Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

    著者: David Jones, Pol Boudes, Mark G. Swain, Christopher L. Bowlus, Michael Galambos, Bruce R. Bacon, Yvonne Döerffel, Norman Gitlin, Stuart C. Gordon, Joseph A. Odin, David Sheridan, M A Wörns, Virginia Clark, Linsey Corless, Heinz Hartmann, Mark Jonas, Andreas E. Kremer, George Mells, Peter Buggisch, B. Freilich, Cynthia Levy, John M. Vierling, David Bernstein, Marek Hartleb, Ewa Janczewska, Fedja A. Rochling, Hemant Shah, Mitchell L. Shiffman, John H. Smith, Yun‐Jung Choi, Alexandra Steinberg, Mónika Varga, Harinder Chera, Robert L. Martin, Charles A. McWherter, Gideon M. Hirschfield - ˜The œLancet. Gastroenterology & hepatology 2017 被引用: 186

  8. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data

    著者: Rohit Loomba, Robert J. Wong, Jeremy Fraysse, Sanatan Shreay, Suying Li, Stephen A. Harrison, Stuart C. Gordon - Alimentary Pharmacology & Therapeutics 2020 被引用: 180

  9. A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis

    著者: Christopher L. Bowlus, Michael Galambos, Richard Aspinall, Gideon M. Hirschfield, David E.J. Jones, Yvonne Dörffel, Stuart C. Gordon, Stephen A. Harrison, Andreas E. Kremer, Marlyn J. Mayo, Paul J. Thuluvath, Cynthia Levy, Mark G. Swain, Guy Neff, David Sheridan, Carmen Stanca, Christoph P. Berg, Aparna Goel, Mitchell L. Shiffman, John M. Vierling, Pol Boudes, Alexandra Steinberg, Yun‐Jung Choi, Charles A. McWherter - Journal of Hepatology 2022 被引用: 79

  10. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients

    著者: W. Ray Kim, Thomas Berg, Tarik Asselah, Robert Flisiak, Scott Fung, Stuart C. Gordon, Harry L.A. Janssen, Pietro Lampertico, Daryl Lau, Jeffrey D. Bornstein, Raul E. Aguilar Schall, Phillip Dinh, Leland J. Yee, Eduardo B. Martins, Seng Gee Lim, Rohit Loomba, Jörg Petersen, Marı́a Buti, Patrick Marcellin - Journal of Hepatology 2015 被引用: 291

  11. Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

    著者: Marc Bourlière, Stuart C. Gordon, Steven L. Flamm, Curtis Cooper, Alnoor Ramji, Myron J. Tong, Natarajan Ravendhran, Simon C. Ling, Tram T. Tran, Stephen Pianko, Meena B. Bansal, Victor de Lédinghen, Robert H. Hyland, Luisa M. Stamm, Hadas Dvory‐Sobol, Evguenia S. Svarovskaia, Jie Zhang, Kaijiao Huang, G. Mani Subramanian, Diana M. Brainard, John G. McHutchison, Elizabeth C. Verna, Peter Buggisch, Charles Landis, Ziad Younes, Michael P. Curry, Simone I. Strasser, Eugene R. Schiff, K. Rajender Reddy, M.P. Manns, Kris V. Kowdley, Stefan Zeuzem - New England Journal of Medicine 2017 被引用: 565

  12. Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment

    著者: Mei Lü, Yueren Zhou, Irina V. Haller, Robert J. Romanelli, Jeffrey J. VanWormer, Carla V. Rodriguez, Heather Anderson, Joseph A. Boscarino, Mark A. Schmidt, Yihe G. Daida, Amandeep Sahota, Jennifer Vincent, Christopher L. Bowlus, Keith D. Lindor, Talan Zhang, Sheri Trudeau, Jia Li, Loralee B. Rupp, Stuart C. Gordon - Clinical Gastroenterology and Hepatology 2017 被引用: 135

  13. Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B

    著者: Anna S. Lok, Calvin Q. Pan, Steven-Huy Han, Huy N. Trinh, W. Jeffrey Fessel, Timothy C. Rodell, Benedetta Massetto, Lanjia Lin, Anuj Gaggar, G. Mani Subramanian, John G. McHutchison, Carlo Ferrari, Hannah Lee, Stuart C. Gordon, Edward Gane - Journal of Hepatology 2016 被引用: 177

  14. Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis

    著者: Marlyn J. Mayo, John M. Vierling, Christopher L. Bowlus, Cynthia Levy, Gideon M. Hirschfield, Guy Neff, Michael Galambos, Stuart C. Gordon, Brian B. Borg, Stephen A. Harrison, Paul J. Thuluvath, Aparna Goel, Mitchell L. Shiffman, Mark G. Swain, David Jones, Palak Trivedi, Andreas E. Kremer, Richard Aspinall, David Sheridan, Yvonne Dörffel, Ke Yang, Yun‐Jung Choi, Charles A. McWherter - Alimentary Pharmacology & Therapeutics 2023 被引用: 35

  15. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

    著者: Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts, Norbert Bräu, Edward Gane, Stephen Pianko, Eric Lawitz, Alexander Thompson, Mitchell L. Shiffman, Curtis Cooper, William Towner, Brian Conway, Peter Ruane, Marc Bourlière, Tarik Asselah, Thomas Berg, Stefan Zeuzem, William Rosenberg, Kosh Agarwal, Catherine Stedman, Hongmei Mo, Hadas Dvory‐Sobol, Lingling Han, Jing Wang, John McNally, Anu Osinusi, Diana M. Brainard, John G. McHutchison, Francesco Mazzotta, Tram T. Tran, Stuart C. Gordon, Keyur Patel, Nancy Reau, Alessandra Mangia, Mark Sulkowski - New England Journal of Medicine 2015 被引用: 850

  16. The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease

    著者: Zobair M. Younossi, Saleh A. Alqahtani, Jesús Funuyet‐Salas, Manuel Romero‐Gómez, Yusuf Yılmaz, Çağlayan Keklikkıran, Khalid Alswat, Ming‐Lung Yu, Chun‐Jen Liu, Jian‐Gao Fan, Ming‐Hua Zheng, Patrizia Burra, Sven Francque, Laurent Castéra, Jörn M. Schattenberg, Philip N. Newsome, Alina M. Allen, Mohamed El‐Kassas, Sombat Treeprasertsuk, Saeed Hameed, Vincent Wai‐Sun Wong, Shira Zelber‐Sagi, Kazuhiro Takahashi, Takumi Kawaguchi, Marlen I. Castellanos Fernández, Ajay Duseja, Marco Arrese, Mary E. Rinella, Ashwani K. Singal, Stuart C. Gordon, Michael Fuchs, Wayne Eskridge, Naim Alkhouri, Kenneth Cusi, Rohit Loomba, Jane Ranagan, Achim Kautz, Janus P. Ong, Marcelo Kugelmas, Yuichiro Eguchi, M. Diago, Lynn H. Gerber, Brian Lam, Lisa Fornaresio, Fatema Nader, C Wendy Spearman, Stuart K. Roberts, Wah‐Kheong Chan, Marcelo Silva, Andrei Racila, Pegah Golabi, Prooksa Ananchuensook, Linda Henry, Maria Stepanova, Patrizia Carrieri, Jeffrey V. Lazarus - JHEP Reports 2024 被引用: 31

  17. Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

    著者: Eric Lawitz, Alessandra Mangia, David Wyles, M. Rodríguez‐Torres, Tarek Hassanein, Stuart C. Gordon, Michael Schultz, Mitchell Davis, Zeid Kayali, K. Rajender Reddy, Ira M. Jacobson, Kris V. Kowdley, Lisa M. Nyberg, G. Mani Subramanian, Robert H. Hyland, Sarah Arterburn, Deyuan Jiang, John McNally, Diana M. Brainard, William T. Symonds, John G. McHutchison, Aasim Sheikh, Zobair M. Younossi, Edward Gane - New England Journal of Medicine 2013 被引用: 1,782

  18. Clinical assessment for high‐risk patients with non‐alcoholic fatty liver disease in primary care and diabetology practices

    著者: Zobair M. Younossi, Kathleen E. Corey, Naim Alkhouri, Mazen Noureddin, Ira M. Jacobson, Brian Lam, Stephen Clement, Rita Basu, Stuart C. Gordon, Natarajan Ravendhra, Puneet Puri, Mary E. Rinella, Peter Scudera, Ashwani K. Singal, Linda Henry - Alimentary Pharmacology & Therapeutics 2020 被引用: 93

  19. Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems

    著者: Mei Lü, Jia Li, Irina V. Haller, Robert J. Romanelli, Jeffrey J. VanWormer, Carla V. Rodriguez, Marsha A. Raebel, Joseph A. Boscarino, Mark A. Schmidt, Yihe G. Daida, Amandeep Sahota, Jennifer Vincent, Christopher L. Bowlus, Keith D. Lindor, Loralee B. Rupp, Stuart C. Gordon, Rene Everline, Zahra Daar, Christina Melkonian, Talan Zhang, Yueren Zhou, Hank Wu, Dana Larkin, Nishat Islam, Nonna Akkerman, Sheri Trudeau, Diane Kohnhorst, Sally F. Shaw, Vicki Y. Chiu, Judy Donald, M.F. Turner, Kevin Rubenstein, Jacquelyn Redd, Carmen Wong, Joanne Mor, Kathy Bow, Lisa E. Pieper, Heather Anderson, Nathan Tesch, Solomon Trimble, Mario J. De Los Santos, Tina Amlin, Shamyal Khan, Kevin Dunlap - Clinical Gastroenterology and Hepatology 2017 被引用: 79

  20. Real-world Comorbidity Burden, Health Care Utilization, and Costs of Nonalcoholic Steatohepatitis Patients With Advanced Liver Diseases

    著者: Robert J. Wong, Nandita Kachru, Diane Martinez, Meghan Moynihan, A. Burak Ozbay, Stuart C. Gordon - Journal of Clinical Gastroenterology 2020 被引用: 48

  21. A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection

    著者: Andrew J. Muir, Sanjeev Arora, Gregory T. Everson, Robert Flisiak, Jacob George, Reem Ghalib, Stuart C. Gordon, Todd Gray, Susan Greenbloom, Tarek Hassanein, Jan Hillson, Maria Arantxa Horga, Ira M. Jacobson, Lennox Jeffers, Kris V. Kowdley, Eric Lawitz, Stefan Lueth, M. Rodríguez‐Torres, Vinod K. Rustgi, Lynn Shemanski, Mitchell L. Shiffman, Subasree Srinivasan, Hugo E. Vargas, John M. Vierling, Dong Xu, Juan Carlos López-Talavera, Stefan Zeuzem - Journal of Hepatology 2014 被引用: 147

  22. Advancing Age and Comorbidity in a US Insured Population‐Based Cohort of Patients With Chronic Hepatitis B

    著者: Mindie H. Nguyen, Joseph K. Lim, A. Burak Ozbay, Jeremy Fraysse, Iris Liou, Nicole Meyer, Geoffrey Dusheiko, Stuart C. Gordon - Hepatology 2018 被引用: 87

  23. Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

    著者: Kris V. Kowdley, Stuart C. Gordon, K. Rajender Reddy, Lorenzo Rossaro, David Bernstein, Eric Lawitz, Mitchell L. Shiffman, Eugene R. Schiff, Reem Ghalib, Michael J. Ryan, Vinod K. Rustgi, Mario Chojkier, Robert Herring, Adrian M. Di Bisceglie, Paul J. Pockros, G. Mani Subramanian, Di An, Evguenia S. Svarovskaia, Robert H. Hyland, Phillip S. Pang, William T. Symonds, John G. McHutchison, Andrew J. Muir, David Pound, Michael Fried - New England Journal of Medicine 2014 被引用: 1,125

  24. Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

    著者: Ira M. Jacobson, Stuart C. Gordon, Kris V. Kowdley, Eric M. Yoshida, M. Rodríguez‐Torres, Mark Sulkowski, Mitchell L. Shiffman, Eric Lawitz, Gregory T. Everson, Michael Bennett, Eugene R. Schiff, M. Tarek Al-Assi, G. Mani Subramanian, Di An, M. Lin, John McNally, Diana M. Brainard, William T. Symonds, John G. McHutchison, Keyur Patel, Jordan J. Feld, Stephen Pianko, David R. Nelson - New England Journal of Medicine 2013 被引用: 1,082